Diabetes, Cardiovascular and Heart Diseases  Article 293     Published on January 20, 2018

Psoriasis is a common inflammatory dermatological or skin disease and a long-lasting autoimmune disease. About 2 to 4 percent of the adults were affected by psoriasis disease. Earlier studies show psoriasis association with the heart attack (the medical name is myocardial infarction), cardiovascular diseases, stroke, mortality, type 2 diabetes (T2D) and chronic inflammation.

A study by researchers at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, the United States show risk of the development of type 2 diabetes (T2D) among people with psoriasis and the quantum of type 2 diabetes (T2D) risk increases along with the severity of the psoriasis disease. This is the first study exploring the effects of type 2 diabetes (T2D) with the severity of psoriasis disease. This study has found a biological connection between type 2 diabetes (T2D) and psoriasis and also show psoriasis disease promotes insulin resistance.

Researchers have conducted studies with a group of 8,124 psoriasis individuals and another group of 76,599 individuals without psoriasis disease. They collected body surface area (BSA) of psoriasis patients, which indicates the severity of the psoriasis disease. They have done follow up studies for a period of four years. Follow up studies show new diabetes development in 280 (3.44 percent) individuals in psoriasis group and 1,867 (2.44 percent) individuals in the non-psoriasis group. After adjusting their findings with other risk factors to type 2 diabetes (T2D) such as the age of an individual, sex, obesity or body mass index (BMI) etc, researchers found

• About 21 percent increased risk of development of type 2 diabetes (T2D) among the psoriasis-affected patients with BSA up to two percent compared to non-psoriasis individuals.
• About 64 percent higher risk of the development of type 2 diabetes (T2D) among psoriasis-affected patients with BSA of ten percent or more compared to non-psoriasis individuals.
• For every 10 percent increase in BSA, the risk of the development of type 2 diabetes (T2D) increases by 20 percent among psoriasis patients relatives to non-psoriasis patients.

Researchers say healthcare professionals should provide special attention for the prevention of type 2 diabetes (T2D) among psoriasis patients with BSA more than 10 as they are at higher risk. Lead author of the study was Joel M. Gelfand, a professor of dermatology and epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, the United States. The study findings were published November 8, 2017, in the Journal of the American Academy of Dermatology. Title of the article was "Psoriasis and the Risk of Diabetes: A Prospective Population-Based Cohort Study."
DOI : doi.org/10.1016/j.jaad.2017.10.050

       
If you like this article, please share it with a friend! Article address is (copy and paste the code below) :

Articles similar to this topic

1. Study show duration of the psoriasis disease increases risk of inflammation in blood vessels, cardiovascular diseases, heart attack and stroke
2. Risks With Psoriasis
3. Risk of type 2 diabetes, type 1.5 diabetes or latent autoimmune diabetes in adults (LADA) with high salt or sodium consumption
4. MonoPepT1De trial show slowdown in the development of type 1 diabetes with a retrained immune system
5. Inflammation hormones risk with glucose-gobbling immune cells hidden in plaque of coronary artery disease CAD patients
6. BCG vaccine could restore proper immune response in type 1 diabetes
7. Autoimmune Diseases Decreases With Physical Exercise
8. Transplanting Bone Marrow To Cure Autoimmune Diseases
9. Risk Reduction To Inflammation Related Heart Diseases With Coffee Consumption
10. Raspberries could lower inflammation, high blood sugar or glucose levels and improves insulin sensitivity
11. A CT scan that can detect human coronary inflammation and helps us in gauging heart attack risk
12. Reduced heart inflammation by eating brightly colored lutein carotenoid vegetables
13. Lower risk of obesity and type 2 diabetes with the consumption of whole grains and milled whole grains
14. Ozempic (semaglutide) GLP-1 type 2 diabetes drugs from Novo Nordisk can reduce obesity and body fat levels

Site maps

Site map 1   Site map 2   Site map 3   Site map 4

The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.

Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.